Virtus ETF Advisers LLC Bridge Bio Pharma, Inc. Transaction History

Virtus ETF Advisers LLC

  • $234 Million
  • Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 12,637 shares of BBIO stock, worth $443,685. This represents 0.15% of its overall portfolio holdings.

Number of Shares
12,637
Previous 11,357 11.27%
Holding current value
$443,685
Previous $289,000 19.72%
% of portfolio
0.15%
Previous 0.14%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$22.35 - $29.5 $28,608 - $37,760
1,280 Added 11.27%
12,637 $346,000
Q2 2024

Aug 14, 2024
BUY
$23.0 - $31.04 $17,158 - $23,155
746 Added 7.03%
11,357 $287,000
Q1 2024

May 15, 2024
BUY
$27.35 - $40.45 $41,763 - $61,767
1,527 Added 16.81%
10,611 $328,000
Q4 2023

Feb 15, 2024
SELL
$24.02 - $43.89 $214,594 - $392,113
-8,934 Reduced 49.58%
9,084 $366,000
Q3 2023

Nov 07, 2023
SELL
$16.89 - $35.01 $39,303 - $81,468
-2,327 Reduced 11.44%
18,018 $475,000
Q2 2023

Aug 14, 2023
SELL
$13.29 - $18.01 $158,190 - $214,373
-11,903 Reduced 36.91%
20,345 $349,000
Q1 2023

May 15, 2023
BUY
$7.17 - $18.55 $4,065 - $10,517
567 Added 1.79%
32,248 $534,000
Q4 2022

Feb 14, 2023
SELL
$6.74 - $11.52 $30,289 - $51,770
-4,494 Reduced 12.42%
31,681 $241,000
Q3 2022

Nov 14, 2022
BUY
$7.94 - $12.36 $4,200 - $6,538
529 Added 1.48%
36,175 $360,000
Q2 2022

Aug 12, 2022
BUY
$5.21 - $12.14 $164,578 - $383,490
31,589 Added 778.63%
35,646 $324,000
Q1 2022

May 16, 2022
SELL
$7.34 - $17.16 $1,812 - $4,238
-247 Reduced 5.74%
4,057 $41,000
Q4 2021

Feb 14, 2022
BUY
$11.38 - $53.41 $11,015 - $51,700
968 Added 29.02%
4,304 $72,000
Q3 2021

Nov 15, 2021
SELL
$46.87 - $64.24 $8,108 - $11,113
-173 Reduced 4.93%
3,336 $156,000
Q2 2021

Aug 10, 2021
SELL
$46.47 - $63.93 $64,732 - $89,054
-1,393 Reduced 28.42%
3,509 $214,000
Q1 2021

May 17, 2021
BUY
$55.47 - $72.35 $4,548 - $5,932
82 Added 1.7%
4,902 $302,000
Q4 2020

Feb 12, 2021
SELL
$38.38 - $71.11 $227,708 - $421,895
-5,933 Reduced 55.18%
4,820 $343,000
Q3 2020

Nov 13, 2020
SELL
$27.2 - $42.19 $39,657 - $61,513
-1,458 Reduced 11.94%
10,753 $403,000
Q2 2020

Aug 05, 2020
BUY
$22.22 - $35.69 $52,239 - $83,907
2,351 Added 23.84%
12,211 $398,000
Q1 2020

May 14, 2020
SELL
$16.11 - $36.23 $23,117 - $51,990
-1,435 Reduced 12.7%
9,860 $286,000
Q4 2019

Feb 13, 2020
BUY
$17.96 - $46.63 $202,858 - $526,685
11,295 New
11,295 $396,000

Others Institutions Holding BBIO

# of Institutions
320
Shares Held
176M
Call Options Held
13M
Put Options Held
2.48M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $5.2B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email